Cargando…
Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
BACKGROUND: Myocardial fibrosis is an important pathophysiologic mechanism of cardiac involvement that leads to increased mortality in patients with autoimmune diseases (AIDs). The aim of this study was to evaluate the association between myocardial strain from speckle-tracking echocardiography (STE...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899104/ https://www.ncbi.nlm.nih.gov/pubmed/35265686 http://dx.doi.org/10.3389/fcvm.2022.836942 |
_version_ | 1784663831671209984 |
---|---|
author | Jia, Fuwei Li, Xiao Zhang, Dingding Jiang, Shu Yin, Jie Feng, Xiaojin Zhu, Yanlin Liu, Yingxian Zhu, Yuanyuan Lai, Jinzhi Yang, Huaxia Fang, Ligang Chen, Wei Wang, Yining |
author_facet | Jia, Fuwei Li, Xiao Zhang, Dingding Jiang, Shu Yin, Jie Feng, Xiaojin Zhu, Yanlin Liu, Yingxian Zhu, Yuanyuan Lai, Jinzhi Yang, Huaxia Fang, Ligang Chen, Wei Wang, Yining |
author_sort | Jia, Fuwei |
collection | PubMed |
description | BACKGROUND: Myocardial fibrosis is an important pathophysiologic mechanism of cardiac involvement that leads to increased mortality in patients with autoimmune diseases (AIDs). The aim of this study was to evaluate the association between myocardial strain from speckle-tracking echocardiography (STE) and fibrosis on cardiovascular magnetic resonance (CMR) and to further explore their prognostic implications in patients with AIDs. METHODS: We prospectively included 102 AIDs patients with clinically suspected cardiac involvement and 102 age- and sex-matched healthy individuals. Patients underwent CMR for evaluation of myocardial fibrosis by late gadolinium enhancement (LGE) and T1 mapping. A semiquantitative evaluation based on the extent of LGE was used to calculate the total (tLGEs) and segmental (sLGEs) LGE score. Global longitudinal strain (GLS) was evaluated by STE in all subjects. All patients were regularly followed up every 6 months. The primary endpoint was the composite incidence of all-cause death and cardiovascular hospitalization. RESULTS: Compared to healthy controls, AIDs patients had impaired GLS (−17.9 ± 5.1% vs. −21.2 ± 2.5%, p < 0.001). LGE was detected in 70% of patients. Patients with LGE presented worse GLS (−17.1 ± 5.3% vs. −19.6 ± 4.1%, p = 0.018) than those without LGE. On multivariate logistic analysis, GLS ≥ −15% was an independent predictor of LGE presence (OR = 4.98, 95%CI 1.35–18.33, p = 0.016). Moreover, a marked and stepwise impairment of segmental longitudinal strain (−19.3 ± 6.6 vs. −14.9 ± 6.5 vs. −8.9 ± 6.3, p < 0.001) was observed as sLGEs increased. During a median follow-up time of 25 months, 6 patients died, and 14 patients were hospitalized for cardiovascular reasons. Both GLS ≥ −15% (HR 3.56, 95%CI 1.28–9.86, p = 0.015) and tLGEs ≥ 6 (HR 4.13, 95%CI 1.43–11.92, p = 0.009) were independently associated with the primary endpoint. CONCLUSIONS: In AIDs patients, impaired myocardial strain on STE could reflect the presence and extent of myocardial fibrosis and provide incremental prognostic value in addition to LGE in the prediction of adverse outcomes. |
format | Online Article Text |
id | pubmed-8899104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88991042022-03-08 Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases Jia, Fuwei Li, Xiao Zhang, Dingding Jiang, Shu Yin, Jie Feng, Xiaojin Zhu, Yanlin Liu, Yingxian Zhu, Yuanyuan Lai, Jinzhi Yang, Huaxia Fang, Ligang Chen, Wei Wang, Yining Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Myocardial fibrosis is an important pathophysiologic mechanism of cardiac involvement that leads to increased mortality in patients with autoimmune diseases (AIDs). The aim of this study was to evaluate the association between myocardial strain from speckle-tracking echocardiography (STE) and fibrosis on cardiovascular magnetic resonance (CMR) and to further explore their prognostic implications in patients with AIDs. METHODS: We prospectively included 102 AIDs patients with clinically suspected cardiac involvement and 102 age- and sex-matched healthy individuals. Patients underwent CMR for evaluation of myocardial fibrosis by late gadolinium enhancement (LGE) and T1 mapping. A semiquantitative evaluation based on the extent of LGE was used to calculate the total (tLGEs) and segmental (sLGEs) LGE score. Global longitudinal strain (GLS) was evaluated by STE in all subjects. All patients were regularly followed up every 6 months. The primary endpoint was the composite incidence of all-cause death and cardiovascular hospitalization. RESULTS: Compared to healthy controls, AIDs patients had impaired GLS (−17.9 ± 5.1% vs. −21.2 ± 2.5%, p < 0.001). LGE was detected in 70% of patients. Patients with LGE presented worse GLS (−17.1 ± 5.3% vs. −19.6 ± 4.1%, p = 0.018) than those without LGE. On multivariate logistic analysis, GLS ≥ −15% was an independent predictor of LGE presence (OR = 4.98, 95%CI 1.35–18.33, p = 0.016). Moreover, a marked and stepwise impairment of segmental longitudinal strain (−19.3 ± 6.6 vs. −14.9 ± 6.5 vs. −8.9 ± 6.3, p < 0.001) was observed as sLGEs increased. During a median follow-up time of 25 months, 6 patients died, and 14 patients were hospitalized for cardiovascular reasons. Both GLS ≥ −15% (HR 3.56, 95%CI 1.28–9.86, p = 0.015) and tLGEs ≥ 6 (HR 4.13, 95%CI 1.43–11.92, p = 0.009) were independently associated with the primary endpoint. CONCLUSIONS: In AIDs patients, impaired myocardial strain on STE could reflect the presence and extent of myocardial fibrosis and provide incremental prognostic value in addition to LGE in the prediction of adverse outcomes. Frontiers Media S.A. 2022-02-21 /pmc/articles/PMC8899104/ /pubmed/35265686 http://dx.doi.org/10.3389/fcvm.2022.836942 Text en Copyright © 2022 Jia, Li, Zhang, Jiang, Yin, Feng, Zhu, Liu, Zhu, Lai, Yang, Fang, Chen and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Jia, Fuwei Li, Xiao Zhang, Dingding Jiang, Shu Yin, Jie Feng, Xiaojin Zhu, Yanlin Liu, Yingxian Zhu, Yuanyuan Lai, Jinzhi Yang, Huaxia Fang, Ligang Chen, Wei Wang, Yining Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases |
title | Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases |
title_full | Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases |
title_fullStr | Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases |
title_full_unstemmed | Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases |
title_short | Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases |
title_sort | predictive value of echocardiographic strain for myocardial fibrosis and adverse outcomes in autoimmune diseases |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899104/ https://www.ncbi.nlm.nih.gov/pubmed/35265686 http://dx.doi.org/10.3389/fcvm.2022.836942 |
work_keys_str_mv | AT jiafuwei predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT lixiao predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT zhangdingding predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT jiangshu predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT yinjie predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT fengxiaojin predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT zhuyanlin predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT liuyingxian predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT zhuyuanyuan predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT laijinzhi predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT yanghuaxia predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT fangligang predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT chenwei predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases AT wangyining predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases |